Capula Management’s Boston Scientific BSX Stock Holding History

Capula Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$650K	Buy	+15,222	New	+$827K	﹤0.01%	348
2026 Q1	–	Sell	-967	Closed	-$92.2K	–	1090
2025 Q4	$92.2K	Sell	967 -7,025	-88%	-$689K	﹤0.01%	728
2025 Q3	$780K	Buy	7,992 +7,711	+2,744%	+$799K	﹤0.01%	387
2025 Q2	$30.2K	Sell	281 -962	-77%	-$97.3K	﹤0.01%	605
2025 Q1	$125K	Buy	+1,243	New	+$125K	﹤0.01%	595
2023 Q2	–	Sell	-1,357	Closed	-$67.9K	–	465
2023 Q1	$67.9K	Buy	+1,357	New	+$64K	﹤0.01%	649
2021 Q1	–	Sell	-10,105	Closed	-$363K	–	492
2020 Q4	$363K	Buy	+10,105	New	+$364K	0.02%	251
2020 Q3	–	Sell	-10,800	Closed	-$379K	–	159
2020 Q2	$379K	Buy	+10,800	New	+$389K	0.01%	285
2019 Q4	–	Sell	-20,170	Closed	-$844K	–	380
2019 Q3	$821K	Buy	+20,170	New	+$855K	0.02%	265

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capula Management's BSX Position: Q2 2026 in Review

Capula Management opened a new position in Boston Scientific (BSX) in Q2 2026: 15,222 shares worth $650K. The stake represents ﹤0.01% of the portfolio and ranks #348 among its holdings. This is a return to the name: Capula Management previously reported a position in BSX as recently as Q4 2025.

Capula Management first reported a position in BSX in Q3 2019 and has held it in 9 quarters since. The position peaked at $821K in Q3 2019. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Capula Management held 15,222 shares of Boston Scientific worth $650K as of Q2 2026.
Boston Scientific was a new Capula Management position in Q2 2026.
Boston Scientific made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #348 holding.
Capula Management first reported a position in Boston Scientific in Q3 2019 and has held it in 9 quarters since.
Capula Management's Boston Scientific position peaked at $821K in Q3 2019.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.